Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Highland Small-Cap Equity Fund Class A (HSZAX)

Net Asset Value
1 Day
Overall Morningstar Rating
Small growth
Style or Category
Sales Expenses
Expense Ratio
Morningstar Risk Rating™
Investment Objective The investment seeks long-term growth of capital. The fund seeks to achieve its investment objective by investing at least 80% of its net assets under normal circumstances in equity securities, such as common and preferred stocks, of small-cap companies, plus borrowing for investment purposes. The managers define a small-cap company as one with a market capitalization that falls between (a) the bottom range of the Russell 2000 ® Index ("Russell 2000 Index") and (b) the greater of either the top range of the Russell 2000 Index or $3.0 billion.


1 month-1.25% 3 years+11.41%
3 months+2.59% 5 years+14.64%
1 year+24.36% Since inception+10.52%
Data through --

Peer Comparisonvs. Small growth

Performance 5-yr return+14.64%+10.73%
Expense ratio2.02%1.31%
Risk 5 year sharpe ratio0.940.82
Net assets$63.2M$928.1M
Average market cap$1.8B$3.4B
Average P/E17.828.7
Portfolio turnover107%107%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyHighland Funds
Fund manager & tenureJames Dondero / 1 Years
Minimal initial investment$1,000.00
Minimum IRA investment--


U.S. stock97.42%
International stock2.58%
Fixed income0.00%
Top 5 Sectors
Portfolio weighting
Industrial materials 15.20%
Healthcare 13.69%
Financial service 12.40%
Consumer goods 10.64%
Business service 9.24%
Top 10 Holdings
Portfolio weighting
JCAP Jernigan Capital Inc6.54%
PDCO Patterson Companies Inc4.00%
RARE Ultragenyx Pharmaceutical Inc3.71%
PCRX Pacira Pharmaceuticals Inc3.38%
IRT Independence Realty Trust Inc3.30%
RAS RAIT Financial Trust3.28%
WTW Weight Watchers International Inc3.12%
FIG Fortress Investment Group LLC2.87%
ETE Energy Transfer Equity LP2.74%
PTLA Portola Pharmaceuticals Inc2.57%